Comments of DPR's EAD for Abamectin
OEHHA has provided a number of comments on the exposure assessment methodology and conclusions on the draft EAD for Abamectin. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.
- Avermectin B1 (Abamectin)